Srdjan Novaković
- Molecular Biology
- Oncology top 10%
- Genetics top 10%
- Public Health, Environmental and Occupational Health top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Vida StegelJanez ŽgajnarBarbara Jezeršek NovakovićGregor SeršaIrma Virant‐KlunMarko HočevarDamijan MiklavčičMateja Krajc
- Topics
- BRCA gene mutations in cancer (22 papers)Lymphoma Diagnosis and Treatment (13 papers)Immunotherapy and Immune Responses (12 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaInternational Journal of Molecular Sciences
- Partner nations
- SloveniaUnited StatesCzechia
In The Last Decade
Srdjan Novaković
107 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 557
- Oncology 292
- Genetics 230
- Public Health, Environmental and Occupational Health 202
- Pathology and Forensic Medicine 183
Countries citing papers authored by Srdjan Novaković
This map shows the geographic impact of Srdjan Novaković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srdjan Novaković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srdjan Novaković more than expected).
Fields of papers citing papers by Srdjan Novaković
This network shows the impact of papers produced by Srdjan Novaković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srdjan Novaković. The network helps show where Srdjan Novaković may publish in the future.
Co-authorship network of co-authors of Srdjan Novaković
This figure shows the co-authorship network connecting the top 25 collaborators of Srdjan Novaković. A scholar is included among the top collaborators of Srdjan Novaković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srdjan Novaković. Srdjan Novaković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 25 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 17 | |
| 12 | 33 | |
| 13 | 32 | |
| 14 | 15 | |
| 15 | 115 | |
| 16 | 13 | |
| 17 | Rapid detection of most frequent Slovenian germ-line mutations in BRCA1 gene using real-time PCR and melting curve analysis | 2 |
| 18 | Tumor markers in clinical oncology | 10 |
| 19 | 3 | |
| 20 | 20 |
About Srdjan Novaković
Srdjan Novaković is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 114 papers that have together received 1.3k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (22 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunotherapy and Immune Responses (12 papers). The work is most often cited by research in Biotechnology (158 citations), Reproductive Medicine (107 citations) and Oncology (292 citations). Srdjan Novaković has collaborated with scholars based in Slovenia, United States and Czechia. Frequent co-authors include Vida Stegel, Janez Žgajnar, Barbara Jezeršek Novaković, Gregor Serša, Irma Virant‐Klun, Marko Hočevar, Damijan Miklavčič, Mateja Krajc, Eda Vrtačnik Bokal and Branko Cvjetičanin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.